Related Experiment Video
Updated: Jan 24, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
Therapeutic mRNA delivery to leukocytes
Yasmin Granot-Matok1, Edo Kon1, Niels Dammes1
1Laboratory of Precision NanoMedicine, Tel Aviv University, Tel Aviv 69978, Israel; School of Molecular Cell Biology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel; Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv 69978, Israel; Center for Nanoscience and Nanotechnology, and Tel Aviv University, Tel Aviv 69978, Israel; Cancer Biology Research Center, Tel Aviv University, Tel Aviv 69978, Israel.
Messenger RNA (mRNA) therapeutics offer promising treatments by manipulating immune cells. This review explores mRNA delivery to leukocytes, discussing progress, challenges, and technological advancements for broader therapeutic applications.
Area of Science:
- Biotechnology
- Immunology
- Molecular Biology
Background:
- Messenger RNA (mRNA) therapeutics are emerging as a significant class of drugs with broad potential.
- mRNA-based immunotherapy is a pioneering and advanced therapeutic approach.
- Current applications of mRNA primarily involve immune cell manipulation for vaccination.
Purpose of the Study:
- To review the potential of mRNA delivery specifically to leukocytes.
- To provide an overview of current progress and challenges in mRNA therapy for immune cell manipulation.
- To discuss technological developments for overcoming limitations in mRNA therapy.
Main Methods:
- Literature review of mRNA therapeutics and delivery systems.
- Analysis of advancements in mRNA rational design.
- Examination of novel delivery platforms for mRNA.
Main Results:
- mRNA delivery to leukocytes shows significant promise for various therapeutic applications beyond vaccination.
- Key challenges include optimizing delivery efficiency and expanding therapeutic scope.
- Technological innovations in mRNA design and delivery platforms are crucial for progress.
Conclusions:
- mRNA therapeutics hold vast potential for treating diverse diseases through immune cell modulation.
- Overcoming delivery challenges and advancing rational mRNA design are critical for realizing this potential.
- Further research into mRNA delivery to leukocytes can unlock new therapeutic avenues.
Related Concept Videos
Regulated mRNA Transport
Nuclear Export of mRNA
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...

